<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190627044035N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-04-02</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Desensitization of  motion sickness in military pilot students: clinical and fMRI outcomes</public_title>
      <acronym></acronym>
      <scientific_title>Desensitization of  motion sickness in military pilot students: clinical and fMRI outcomes</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>12</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/45795</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The researcher allocate one number to each subject, using a computerized randomization software. Odd number put subject in intervention group one and even number locate him in intervention group two. Both participants and assessors are blinded to this grouping, Blinding description: The participants in each group, after being assigned, became aware of their group's intervention, so they were unaware of the other group's intervention so remained blind to type of the groups. Flight surgeon and flight teacher ( final assessor of efficiency of intervention in flight field) were not aware of the groups allocation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>motion sickness.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group one: only incremental coriolis stimulation therapy ( 20 sessions of cross-coupled coriolis stimulation is performed as follows: the subjects sit on Barany chair while turning in two directions around vertical axis, simultaneously with head motions in up and down, and right and left directions. Time, velocity, and acceleration of rotation are gradually increased until the subjects can tolerate 20 minutes rotation with velocity of 120 degree per seconds, without nausea. Intervention 2: Intervention group two: In addition to Intervention in group one, this group attend at 10 sessions of breathing and relaxation exercises using neurofeedback software, 3 to 5 sessions of consultation by aerospace-trained psychologist, and teaching of balance exercises to daily perform for two weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All raw data will be shared after removing subject names, including brain images and their processed information, videonystagmography, video head impulse test, posturography, questionnaires, and coriolis test on Barany chair, and also study protocol, statistical tables and figures, and informed consent form.

When:
Available from June 2020

To whom:
All addressed and related researchers or organizations

Conditions:
- Application from the referenced university, laboratory, or organization
- Commitment to correctly reference this study

Where to obtain:
Researcher: Mehrnaz Hosseini
E.mail: mehrnaz.hosseini@yahoo.com
No. 11, Mouzeh alley, North Sohrevardi street, Seyyed khandan, Tehran, Iran.

How to obtain:
Application must send to researcher's E.mail and include formal requisition from the related organization. Then the data will be sent to the applicant After confirmation by supervisor at Iran University of Medical Sciences,

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mehrnaz Hosseini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 11, Mouzeh Alley, North Sohrevardi street, Seyyed Khandan</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1555817114</zip>
        <telephone>+98 21 8851 6204</telephone>
        <email>Mehrnaz.Hosseini@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mehrnaz Hosseini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 11, Mouzeh Alley, North Sohrevardi street, Seyyed Khandan</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1555817114</zip>
        <telephone>+98 21 8851 6204</telephone>
        <email>Mehrnaz.Hosseini@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All pilot trainees with remained motion sickness symptoms ( diagnosed by flight surgeon) on three consecutive flights</inclusion_criteria>
      <agemin>21 years</agemin>
      <agemax>24 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Existence of any pathology of gastrointestinal, neurotologic, psychiatry or psychology
Possess any prohibition criteria for MRI, such as clastrophobia or any metal implant in body
No willingness to participate in study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>T75.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Motion sickness</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group one: only incremental coriolis stimulation therapy ( 20 sessions of cross-coupled coriolis stimulation is performed as follows: the subjects sit on Barany chair while turning in two directions around vertical axis, simultaneously with head motions in up and down, and right and left directions. Time, velocity, and acceleration of rotation are gradually increased until the subjects can tolerate 20 minutes rotation with velocity of 120 degree per seconds, without nausea.</i_keyword>
      <i_keyword>Intervention group two: In addition to Intervention in group one, this group attend at 10 sessions of breathing and relaxation exercises using neurofeedback software, 3 to 5 sessions of consultation by aerospace-trained psychologist, and teaching of balance exercises to daily perform for two weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Degree of activation of brain regions. Timepoint: one day before and after intervention period. Method of measurement: functional magnetic resonance imaging (fMRI).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Eye movement response parameters. Timepoint: up to one week before and after intervention period. Method of measurement: videonystagmography (VNG) and video head impulse test (vHIT).</sec_outcome>
      <sec_outcome>Sensory adequacy and organization for postural control. Timepoint: up to one week before and after intervention period. Method of measurement: posturography.</sec_outcome>
      <sec_outcome>Improvement in subjective sense of symptoms. Timepoint: up to one week before and after intervention period. Method of measurement: filling motion sickness assessment questionnaire (MSAQ) and misery scale (MISC) after coriolis stimulation on barany chair.</sec_outcome>
      <sec_outcome>Functional improvement in real flight. Timepoint: up to two weeks after intervention. Method of measurement: report by flight surgeon.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-07-20</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Hemmat highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
